Initial presentation of human papillomavirus‐related head and neck cancer: A retrospective review
- 8 September 2018
- journal article
- review article
- Published by Wiley in The Laryngoscope
- Vol. 129 (4) , 877-882
Abstract
Objective: Human papillomavirus (HPV) has been identified as a risk factor for oropharyngeal squamous cell carcinoma (OPSCC) and a cause of the recent dramatic rise in the incidence of this disease. HPV‐positive OPSCC typically affects a younger population and has no validated screening test. This study aims to outline the common presenting signs of HPV‐positive OPSCC.Methods: We conducted a retrospective single‐institution review on 370 patients who were treated at the Icahn School of Medicine at Mount Sinai, New York City, between April 2007 and November 2015 for OPSCC. We included patients with newly diagnosed OPSCC and sufficient history and physical data in the final analysis. Univariate analysis was used to compare HPV‐positive and HPV‐negative cohorts for demographics, tumor location, tumor staging, initial presentation and symptoms, and physical exam findings.Results: Two hundred and seven patients met the inclusion criteria. The most common initial symptoms for OPSCC were neck mass (51.7%) and sore throat (13.0%). The HPV‐positive cohort was more likely to present with a chief complaint of neck mass compared to the HPV‐negative cohort (56.1% vs. 22.2%; P = 0.0015). A positive neck exam was associated with HPV‐positive status (73.9% vs. 40.7%; P = 0.0012).Conclusion: HPV‐positive OPSCC is an incipient epidemic, poised to surpass cervical cancer as the most common HPV‐related cancer by 2020. Initial presenting signs may often be mistaken for benign processes. This study provides physicians with a better understanding of initial presentation of patients with HPV‐positive OPSCC, leading to earlier diagnosis and improved outcomes.Level of Evidence: 4 Laryngoscope, 129:877–882, 2019Keywords
Funding Information
- Icahn School of Medicine Institutional Review Board (IRB)
- Institutional funding Icahn School of Medicine at Mount Sinai.
This publication has 43 references indexed in Scilit:
- Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa RicaPLOS ONE, 2013
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage LevelsJNCI: Journal of the National Cancer Institute, 2013
- Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal CancerJournal of Clinical Oncology, 2012
- HPV Positive Squamous Cell Carcinoma of the Oropharynx. Are we Observing an Unusual Pattern of Metastases?Head and Neck Pathology, 2012
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Associations between Oral HPV16 Infection and Cytopathology: Evaluation of an Oropharyngeal “Pap-Test Equivalent” in High-Risk PopulationsCancer Prevention Research, 2011
- Oropharyngeal Cancer Epidemic and Human PapillomavirusEmerging Infectious Diseases, 2010
- Human Papillomavirus and Survival of Patients with Oropharyngeal CancerNew England Journal of Medicine, 2010
- A meta-analysis of alcohol drinking and oral and pharyngeal cancers. Part 1: Overall results and dose-risk relationOral Oncology, 2010
- Improved Survival of Patients With Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma in a Prospective Clinical TrialJNCI: Journal of the National Cancer Institute, 2008